Avidity Current Deferred Revenue from 2010 to 2026
| RNA Stock | USD 72.90 0.08 0.11% |
Current Deferred Revenue | First Reported 2019-12-31 | Previous Quarter 13.5 M | Current Value 19.1 M | Quarterly Volatility 8.6 M |
Check Avidity Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avidity Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 6.9 M, Total Revenue of 9.2 M or Research Development of 366.6 M, as well as many indicators such as Price To Sales Ratio of 424, Dividend Yield of 1.0E-4 or PTB Ratio of 2.15. Avidity financial statements analysis is a perfect complement when working with Avidity Biosciences Valuation or Volatility modules.
Avidity | Current Deferred Revenue | Build AI portfolio with Avidity Stock |
Analyzing Avidity Biosciences's Current Deferred Revenue over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Current Deferred Revenue has evolved provides context for assessing Avidity Biosciences's current valuation and future prospects.
Latest Avidity Biosciences' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Avidity Biosciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Avidity Biosciences' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avidity Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Avidity Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 8,101,549 | |
| Geometric Mean | 5,852,785 | |
| Coefficient Of Variation | 101.02 | |
| Mean Deviation | 6,273,546 | |
| Median | 3,840,000 | |
| Standard Deviation | 8,184,574 | |
| Sample Variance | 67T | |
| Range | 24.7M | |
| R-Value | 0.67 | |
| Mean Square Error | 39.5T | |
| R-Squared | 0.45 | |
| Significance | 0 | |
| Slope | 1,084,271 | |
| Total Sum of Squares | 1071.8T |
Avidity Current Deferred Revenue History
About Avidity Biosciences Financial Statements
Avidity Biosciences stakeholders use historical fundamental indicators, such as Avidity Biosciences' Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Avidity Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avidity Biosciences' assets and liabilities are reflected in the revenues and expenses on Avidity Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avidity Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 24.1 M | 12.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:Check out the analysis of Avidity Biosciences Correlation against competitors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. Anticipated expansion of Avidity directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avidity Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.19) | Revenue Per Share | Quarterly Revenue Growth 4.34 | Return On Assets | Return On Equity |
Understanding Avidity Biosciences requires distinguishing between market price and book value, where the latter reflects Avidity's accounting equity. The concept of intrinsic value - what Avidity Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Avidity Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Avidity Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avidity Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Avidity Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.